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Summary
Objectives: This study aims at evaluating the prevalence of
rheumatic diseases in the elderly and its evolution over time. 
Methods: We present a systematic international literature
review of the prevalence of rheumatic diseases in the elderly
and its evolution over time. 
Results: The estimated current prevalence of rheumatic dis-
eases among people aged 65 and more varies between 41%
and 53%, and is similar to estimated prevalence rates in stud-
ies performed before 1990 (35–55%). The prevalence is high
and seems to increase rapidly with age. Furthermore, women
suffer more frequently from rheumatic diseases than men. 
Conclusion: The selected studies included a large range of
methods, making comparisons difficult. However, estimates of
the prevalence of rheumatic diseases in the elderly appear to
be homogeneous in different countries and stable since 1980. 
Keywords: Rheumatic diseases – Prevalence – Evolution – Elderly –
Health – Review.
Chronic diseases, such as cancers, heart diseases, and rheu-
matic diseases have become a new challenge for public
health, since the former major problem, mortality due to
infectious diseases, largely declined in the last century. Such
diseases affect an increasing population of elderly reaching
an increasingly advanced age (Blanc et al. 1995). Among
pathologies affecting the elderly, rheumatic diseases are par-
ticularly frequent. Being the first cause of disability, they
have a pronounced impact on the quality of life, they can be
painful, and they are at the origin of functional troubles and
deformations (CDC 1995; 1999; Raina et al. 1998). Despite
their importance, few systematic studies of their epidemio-
logy in the elderly have been conducted in the international
literature. The aims of our study were to determine the 
current prevalence of rheumatic diseases in the elderly in
different developed countries, to identify possible regional
differences, and to study the evolution of the prevalence
over time based on a systematic literature review. 
Methods
We defined rheumatic diseases by their symptoms (i.e., pain
and mobility limitation) rather than by rigorous diagnostic
criteria (i.e., validation by health professionals) since most
population-based epidemiological data rely on self-reported
symptoms from health surveys. Self-reports do not permit
differentiation between the various types of rheumatic dis-
eases. First, we studied the prevalence rates of rheumatic
diseases found in surveys conducted between 1990 and 2002,
which we have considered as the “current prevalence”. We
did not limit our research to a specific period of prevalence.
Second, we studied the evolution of prevalence rates over
time. For this purpose, we used epidemiological surveys of
rheumatic diseases conducted before 1990 and compared
their results with the estimated current prevalences. 
We excluded surveys conducted in developing countries for
the following reasons: (1) Socio-economic conditions in those
countries are not comparable with those found in industrial
countries (Adebajo 1990); (2) The main rheumatic diseases
are different in developing countries; some are characteris-
tic of these countries, such as the acute tropical polyarthri-
tis, the tuberculous arthritis, or the rheumatic fever; (3)
Many studies in developing countries have been conducted
in samples that were not representative of the general 
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population, but of the rural or urban residents (Adebajo
1990).
To obtain a large sample of publications for our epidemiolog-
ical survey, we used the selection expression “musculoskeletal
diseases OR rheumatic diseases OR arthritis OR rheumatism
OR rheumatic complaints OR chronic diseases OR chronic
conditions” in the Medline database (1966–2002), and
retrieved 83 240 articles. We further restricted our selection
criteria by forcing the inclusion of the words “prevalence”,
“epidemiology”, “burden of disease” or “time trends” to
appear. We obtained 2734 articles published from 1990 to
2002, and 835 articles published before 1990. 
We also found articles by using the terms “rheumatic dis-
eases” and “musculoskeletal diseases” in the Cochrane
Library, on the websites of the American Medical Associa-
tion (http://www.ama-assn.org), National Center of Health
Statistics (http://search.cdc.gov), and American Geriatrics
Society (http://www.americangeriatrics.org), and finally on
the Internet with the research tool Google (http://www.google.
ch). Some additional publications found in the references
section of articles selected above were used as well. 
We then selected articles based on their title and abstract,
and read every article that measured the prevalence of
rheumatic diseases. We kept all population-based surveys
(general health surveys, as well as specific epidemiological
surveys with samples representative of the country popula-
tion) published in English, French, and German that used
our definition. Eventually, 14 articles for the current preva-
lence and 16 for the prevalence before 1990 were retained.
The results of this paper are based on these 30 articles.
One of the major problems faced in this review was that def-
initions and methods were not uniform in the various 
studies. For example, it was often unclear whether acute dis-
eases or post-trauma joint pain had been included. Given
these unclear points, we decided to include all the studies
with self-reported symptoms of rheumatic diseases, but to
separate them so that we can discuss the possible impact of
these unclear points. We therefore decided to assume the
following: (1) When rheumatic diseases had been defined on
the basis of symptoms lasting more than six weeks or defined
as rheumatisms, acute diseases and trauma had likely been
excluded. (2) When complaints in the preceding four weeks
had been taken in consideration, acute diseases and trauma
had been likely included. (3) When arthritis had been taken
into consideration without any period of prevalence, acute
diseases had been likely included. (4) When not mentioned,
persons in institutions had been likely included. 
Results
Estimations of the current prevalence of rheumatic diseases
for people aged 65 and older varied between 41% and 53%
(Badley et al. 1994; CDC 1994; 2000; van den Bos 1995;
Lawrence et al. 1998; Desai et al. 1999; Laiho et al. 2001; Tab.
1). One study obtained a higher prevalence, despite the use
of a severity criterion to define rheumatic diseases (pain last-
ing more than one week; Ballina Garcia et al. 1994). The
authors explained the difference by the fact that the inter-
view had been conducted by a rheumatologist. They men-
tioned a study by Allander et al. (1973) that showed that
interviews conducted by non-physicians tended to lead to an
underestimated prevalence. Ballina Garcia et al. (1994) also
suggested environmental and socio-cultural reasons. Only
one study, conducted in the United States in 1995–96 
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Table 1 Estimates of current prevalence for people aged 65 and more
Date and location of survey Period of prevalence Age [yr] Particularities of Prevalence Ref
[months] definition, subjects, etc. [%]
#S A T I
1996–98, USA 12 ≥ 65 N/A + + – 53 (52–55)a 1
1995–96, USA 12 ≥ 65 ~31,497 + + – 49 2
M:41 W:55
~1993–94, Amsterdam, NL N/A 55–79 9,998 + + + 47 3
1989–91, USA 12 ≥ 65 ~31,190 + + – 49 4; 5 
1990, Ontario, CA N/A ≥ 65 N/A – – N/A 43 6
1990, Asturies, E 12 ≥ 65 ~37 + + – 68 7
1989–90, Helsinki & Vantaa, SF N/A ≥ 65 1,317 + + – 41 8
M = men; W = women; #S = number of subjects in the age range of interest.; + = included; – = excluded; A = acute diseases; T = trauma, I = institu-
tionalized persons; N/A = not available, ref = references
~ Indicates that the total number of participants as been calculated based on the number of affected participants and the prevalence
a Only study with 95% CI
References: (1) CDC (2000); (2) Desai et al. (1999); (3) van den Bos (1995); (4) Lawrence et al. (1998); (5) CDC (1994); (6) Badley et al. (1994); (7) Ballina
Garcia et al. (1994); (8) Laiho et al. (2001)
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(Desai et al. 1999), measured the prevalence for both gen-
ders: prevalence estimates were significantly higher for
women (55%) than for men (41%). 
Table 2 summarizes a set of studies emphasizing the varia-
tion of the prevalence estimates as a function of the age class
and period of prevalence, for both sexes. It suggests that
prevalence rates increase with age, for both sexes, as the
range of published prevalence estimates is generally higher
in the oldest age groups.
The estimated current prevalence rates for people older
than 65 are similar to the estimated prevalence rates in stud-
ies performed before 1990 (35%–55%) (Taylor & Ford
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Table 2 Range of current prevalence estimates measured in studies by age and period of prevalence, for both genders
Sex Period of prevalence 65–74 yr old 75–84 yr old ≥ 75 yr old ≥ 85 yr old
Prev [%] Ref Prev [%] Ref Prev [%] Ref Prev [%] Ref
Men altogether 40–44 1–5 46–47 1; 4 40–50 2; 3; 5 42–47 1; 4; 6
point 44 3 – – 50 3 – –
4 weeks – – – – – – 47 6
12 months 44 1 46 1 – – 42 1
lifetime 40 5 – – 44 5 – –
N/A 36–41 2; 4 47 4 40 2 44 4
Women altogether 46–59 1–5 56–61 1; 4 52–66 2; 3; 5 60–63 1; 4; 6
point 56 3 – – 66 3 – –
4 weeks – – – – – – 62 6
12 months 52 1 61 1 – – 63 1
lifetime 54 5 – – 60 5 – –
N/A 46–59 2; 4 56 4 52 2 59 4
Men and altogether 42–51 2; 3; 7; 8 55 8; 9 48–59 2; 3; 7 57 6; 8
Women point – – – – 59 3 – –
together 4 weeks 51 3 – – – – 57 6
12 months 45 7; 8 55 8; 9 55 7 57 8
lifetime – – – – – – – –
N/A 42 2 – – 48 2 – –
Legend: Prev = Prevalence; N/A = not available; Ref = references; References: (1) CDC (2001); (2) Badley et al. (1995); (3) Badley & Wang (1998); 
(4) March et al. (1998); (5) Parker et al. (1997); (6) van Schaardenburg et al. (1994); (7) Desai et al. (1999); (8) CDC (1994); (9): Lawrence et al. (1998)
Table 3 Prevalence estimates for people aged 65 and more in studies conducted before 1990
Date and location of survey Period of prevalence Age [yr] Definition, subjects. Prevalence [%] Ref
#S A T I
1986, Cardiff, UK a) point ≥ 65 712 + + + M: 41 W: 49 1
b) lifetime ≥ 65 712 + + + M: 57 W: 72 1
1986, NL N/A ≥ 65 N/A – – N/A 35 2
1985, S 12 mo 50–70 900 sympt. ≥ 6 wk + 37.8 (33.3–42.3)a 3 
1984, USA a) 12 mo ≥ 60 13,807 + – – 49 4;5
b) 12 mo ≥ 70 13,807 + 55 4;5
1983–85, USA 12 mo ≥ 65 N/A + – – M: 38 W: 54 6
~1983–84, Aberdeen, UK N/A ≥ 60 619 + + – 36 7
1982, D 4 weeks ≥ 65 N/A + + + ~ 8 8
1978–79, CA N/A ≥ 65 2,019 + + N/A 48 9
M: 39 W: 56
1976, SF N/A ≥ 54 N/A – – + M: 28 W: 36 10
1971–72, Goteborg, S lifetime ≥ 70 N/A every week + M: 32 W: 56 11
1970–71, F N/A ≥ 65 N/A – – N/A ~50 12
1959-60, Tecumseh, USA lifetime ≥ 70 289 + + + M: 45 W: 64 13
#S = number of subjects in the age range of interest; + = included; _ = excluded; A = acute diseases; T= trauma; I= institutionalized persons; M: men,
W: women; N/A = not available. References: (1) Vetter et al (1990), (2) Valkenburg (1988), (3) Jacobsson et al (1989), (4) Yelin (1992), (5) Guralnik et al
(1989), (6) Verbrugge et al (1995), (7) Taylor et al. (1984), (8) Moser et al (1986), (9) Lee et al. (1985), (10) Klaukka et al. (1982), (11) Svanborg
(1978), (12) Moser et al. (1986) and (13) Mikkelsen et al. 1967)
a sole study that reports a 95%CI
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1984; Lee et al. 1985; Moser & Ackermann-Liebrich 1986;
Valkenburg 1988; Jaccobsson et al. 1989; Guralnik et al.
1989; Yelin 1992; Verbrugge & Patrick 1995; Tab. 3). One
survey (Deutscher Mikrozensus 1982), however, obtained a
lower prevalence (8%) because only severe cases were
reported (Moser & Ackermann-Liebrich 1986). There is no
evidence for an evolution over time.
The United States is the only country where sufficient sur-
veys with similar definitions and methods were conducted
(Tab. 1 and 3). In this country, the estimated prevalences
between 1959 and 1998 ranged between 49% and 55% (Tab.
1 and 3) and there is again no evidence for an evolution over
time. The trend of increasing prevalence with increasing age
is also found in studies previous to 1990 (Tab. 4).
Discussion
Although many publications refer to the high prevalence of
rheumatic diseases in industrialized countries, few studies
provide data with sufficient methodological details. In addi-
tion, the variety of definitions and methods found in the 
literature is a serious obstacle to the study of time trends and
to international comparison. For instance, many studies con-
sider different periods of prevalence. They may or may not
use severity criteria, and include or exclude people suffering
from back pain or being hospitalized. When severity criteria
are used, the prevalence drops. Our review shows that the
inclusion of elderly in institutions does not significantly
affect the prevalence, as previously noted by Badley & Wang
(1998). Otherwise the inclusion of acute diseases, trauma or
back pain does not seem to affect the prevalence. This result
is surprising since, for example, back pain is frequent in the
general population (Walker 2000). Furthermore, the review
reveals a lack of data for the prevalence of rheumatic dis-
eases in the persons aged 85 and more. 
According to our literature review, the various estimates 
of the current prevalence of rheumatic diseases in the older
than 65 are similar (Tab 1): they vary between 41% and
53%. This similarity suggests that the prevalence is compa-
rable among the studied countries.
Furthermore, our literature review shows that prevalences
found after 1990 are similar to those found before that year
(Tab. 1 and 3). Indeed, prevalence estimates found before
1990 range between 35% and 55%, thus showing no evi-
dence for an evolution in time. This stability in time is sup-
ported by the similar prevalence rates observed in surveys
conducted in the United States between 1959 and 1998 that
used comparable definitions and methods for several years
(Tab. 1 and 3). In contrast, Miles et al. (1993) found an
increase in prevalence over time over earlier decades. They
compared the prevalence of rheumatic diseases in popula-
tion surveys conducted by the National Center of Health
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Table 4 Range of prevalence estimates measured in studies conducted before 1990, by age and period of prevalence, for both genders
Sex Period of prevalence ≥ 65 yr old ≥ 65–74 yr old ≥ 75 yr old
P [%] Ref P [%] Ref P [%] Ref
Men altogether 28–57 1–5 22–58 2; 6–8 29–67 2; 5; 6;9
point 41 2 22–39 2; 7; 8 32–50 2
4 weeks – – – – – –
12 months – – – – – –
lifetime 31–57 2; 4; 5 55–58 2 30–67 2; 5; 9
N/A 28–39 1; 3 37 6 29 6
Women altogether 34–72 1–5 26–73 2; 6–8 42–79 2; 5; 6; 9
point 49 2 26–52 2; 7; 8 42–55 2
4 weeks – – – – – – –
12 months – – – – – –
lifetime 34–72 2; 4; 5 72–73 2 62–79 2; 5; 9
N/A 36–56 1; 3 58 6 59 6
Men and altogether 35– 1; 6, 10; 11–15 40–47 16–18 52–70 16; 17; 19
Women point 55* – – – – –
together 4 weeks – 10 – – – –
12 months 8 11–14 47 16; 17 52 16; 17
lifetime 38–55 – 40 18 – –
N/A – 1; 6; 10; 15 – – 70 19
35–50
P = prevalence, ref = references, N/A = not available
* one study obtained a result of 8 % for this category (21), but considered only the serious conditions. We do not use this value in this review. Refer-
ences: (1) Lee et al. (1985), (2) Vetter et al. (1990), (3) Klaukka et al. (1982), (4) Svanborg (1978), (5) Mikkelsen et al. (1967), (6) Valkenburg (1988), (7)
Bjelle et al. (1980), (8) Bjelle & Allander (1981), (9) Laine (1962), (10) Moser & Ackermann-Liebrich (1986), (11) Jacobsson et al. (1989), (12) Guralnik et
al. (1989), (13) Yelin (1992), (14) Verbrugge & Patrick (1995), (15) Taylor & Ford (1984), (16) Lawrence et al. (1989), (17) Collins (1988), (18) Cunning-
ham & Kelsey (1984) and (19) Ford et al. (1988)
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Statistics in the United States between 1960–62 and 1976–80.
After standardisation to the population in 1970, the preva-
lence was higher in 1976–1980 than in 1960–62, except for
people 70–74 years old. 
At least three hypotheses could explain the discrepancy
between the conclusions of Miles et al. (1993) and ours:
1) The apparent stability of the prevalence estimates in our
review does not reflect appropriately the reality. Since our
review included several studies in time and in geograph-
ical places, we are inclined to believe that this hypothesis
is improbable. 
2) The Miles et al. study had a too limited sample. Indeed,
those authors used only 2 studies and limited their sam-
ple to people younger than 74 years old. Since the preva-
lence of rheumatic diseases diminishes for ages between
70 and 74 in their data, it is possible that the trend reverts
after an age of 70. 
3) Health in old age has improved after the end of the 1970s.
In our literature review, two studies only have been
found before 1980. Six studies were identified between
1983 and 1998 and they reported a prevalence ranging
between 49% and 53%. This strongly suggests that the
prevalence has been stable since the 1980s. The study of
Miles et al. reveals a possible worsening of health
between 1960 and 1970. It does not contradict a possible
improvement of health in old age after 1980. This
hypothesis is difficult to prove since we lack studies
before 1980. 
The majority of the studies incorporated in our review are
based on population surveys using data from interviews. In
addition to the problems of definition, the reproducibility
and the validity of such surveys may be problematic (Cobb
et al. 1955; Lawrence 1977; Magi et al 1984; Ford et al. 1988;
Beckett et al. 2000). According to Lawrence (1977), Magi et
al. (1984) and Cobb et al. (1955), the prevalences obtained
through population surveys based on interviews are under-
estimated. The estimates of the prevalence found in the last
10 years are closer to each other than the earlier preva-
lences, probably because of improvements in survey
methodology.
Despite the limitations described above, since the results of
the different studies are similar, we believe that our results
are suitable. Probably, the inclusion or exclusion of acute
diseases, trauma, and institutionalized persons did not give
different results, because (1) the majority of the elderly have
chronic rheumatic diseases rather than acute rheumatic dis-
eases, (2) part of the trauma by the elderly are linked to sub-
jacent chronic diseases, and (3) the proportion of elderly
who are institutionalized is low. We argue that those who did
not report their diseases are those whose disease did not
interfere mainly with their everyday-life, and consequently
they are probably not those in need for health services. Since
we were interested in the burden of disease, we believe that
our results reflect it appropriately, even if they may under-
estimate the true prevalence of rheumatic diseases.
Conclusions
The prevalence of rheumatic diseases appears to be homo-
geneous in different countries and stable since 1980.
Rheumatic diseases are frequent and affect about half the
population of people older than 65. 
The homogeneity of the prevalence between countries, at
least since 1980, suggests that their populations share the
same characteristics in terms of risk factors for rheumatic
diseases. In addition, the stability of estimates over time is in
favour of a health improvement of elderly people. Indeed,
assuming that the health of elderly was stable in time, an
increase in the prevalence would be expected, since the fre-
quency of rheumatic diseases seems to increase with age
(Tab. 2 and 4) and since the proportion of very old people
increases within the elderly. 
Epidemiological surveys should use standardized methods
with the same definition to facilitate comparisons between
countries and in time. Furthermore, reports should system-
atically mention what is included in the definition of
rheumatic diseases (acute diseases, trauma, gout, etc.), the
studied period of prevalence and whether persons in institu-
tion are included.
In face of the large proportion of the population affected by
rheumatic diseases, primary, secondary, and tertiary preven-
tive measures must be taken to decrease the risk of occur-
rence of rheumatic diseases and to improve the quality of
life. Such diseases have, however, no easy treatment. A pri-
mary preventive measure could be the elimination of risk
factors such as obesity and occupational risk factors. 
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Zusammenfassung
Die Prävalenz rheumatischer Krankheiten bei älteren Men-
schen und deren Entwicklung
Fragestellung: Ziel dieser Studie ist die Untersuchung der Prä-
valenz rheumatischer Krankheiten bei Menschen im Alter von
über 65 Jahren sowie die Entwicklung in den letzten Jahrzehn-
ten.
Methoden: Wir führten einen systematischen Review der
internationalen Literatur zur Prävalenz rheumatischer Krank-
heiten im Alter durch. 
Ergebnisse: Die Einschätzung der gegenwärtigen Prävalenz
rheumatischer Erkrankungen im Alter liegt zwischen 41% und
53%, und entspricht den Ergebnissen der Prävalenzstudien von
vor 1990 (35–55%). Die Prävalenz ist hoch und scheint mit
zunehmendem Alter anzusteigen. Weiterhin sind mehr Frauen
als Männer betroffen. 
Schlussfolgerungen: Trotz einer grossen Auswahl an Metho-
den, die den Vergleich zwischen verschiedenen Studien
erschwert, scheint die Prävalenz rheumatischer Erkrankungen
im Alter im internationalen Vergleich homogen und seit 1980
stabil zu sein.
Résumé
La prévalence des maladies rhumatismales chez les personnes
âgées et son évolution dans le temps
Objectifs: Cette étude a pour but d’étudier la prévalence des
maladies rhumatismales chez les personnes âgées et son évolu-
tion dans le temps.
Méthodes: Une revue de littérature systématique et interna-
tionale consacrée à la prévalence des maladies rhumatismales
chez les personnes âgées et à son évolution.
Résultats: La prévalence actuelle des maladies rhumatismales
chez les personnes âgées de plus de 65 ans est de 41% à 53%;
elle est similaire aux estimations des taux de prévalence trou-
vés dans les études antérieures à 1990 (35–55%). La prévalence
des maladies rhumatismales est élevée et semble augmenter
avec l’âge. De plus, les femmes sont plus fréquemment
atteintes de maladies rhumatismales que les hommes.
Conclusions: Les études sélectionnées ont recouru à diverses
méthodes, rendant délicate toute comparaison. Cependant, la
prévalence des maladies rhumatismales chez les personnes
âgées semble être homogène entre pays et stable depuis 1980.
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